Education and Training
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity
The purpose of this trial was to determine the efficacy and safety of supplemental therapeutic oxygen for infants with prethreshold retinopathy of prematurity (ROP) to reduce the probability of progression to threshold ROP and the need for peripheral retinal ablation.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- procedure: Supplemental Oxygen Management
- procedure: Conventional Oxygen Management
Eligibility
Inclusion Criteria:
- Infants with prethreshold retinopathy of prematurity, confirmed by 2 certified
ophthalmologic exams
- Median pulse oxygen saturation <94% in room air
- Median pulse oxygen saturation can be kept safely >96% on oxygen/ventilator
Exclusion Criteria:
- No fatal congenital anomaly or congenital eye anomaly
Ages Eligible for Study
N/A - 48 Hours
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Not Recruiting